| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJM199406303302608 |
| P698 | PubMed publication ID | 8196732 |
| P2093 | author name string | Mills JA | |
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 1871-1879 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Systemic lupus erythematosus | |
| P478 | volume | 330 |
| Q36536962 | A female preponderance for chemically induced lupus in SJL/J mice |
| Q99551740 | A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model |
| Q40666395 | Aberrant HS1 molecule in a patient with systemic lupus erythematosus |
| Q36426921 | Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice |
| Q80114007 | Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre study |
| Q34994756 | Acute kidney injury associated with minimal change disease in systemic lupus erythematosus: a case report |
| Q41133422 | Adhesion molecules in autoimmune disease |
| Q48014273 | Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD. |
| Q35609293 | Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients |
| Q87568136 | Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q37486571 | Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. |
| Q33746862 | Anti-DNA autoantibodies and systemic lupus erythematosus |
| Q36853705 | Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus. |
| Q37270868 | Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases |
| Q34639465 | Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis |
| Q43848180 | Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. |
| Q36229560 | BAFF and MyD88 signals promote a lupuslike disease independent of T cells |
| Q40414078 | Biology of human TH1 and TH2 cells |
| Q44363698 | Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy |
| Q73343916 | CD137‐Mediated T Cell Co‐Stimulation Terminates Existing Autoimmune Disease in SLE‐Prone NZB/NZW F1 Mice |
| Q36536913 | CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice |
| Q36984865 | CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases |
| Q41324595 | Central serous chorioretinopathy in patients with systemic lupus erythematosus |
| Q34897189 | Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study |
| Q53442368 | Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus. |
| Q35609121 | Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus |
| Q34309764 | Combination treatment in autoimmune diseases: systemic lupus erythematosus. |
| Q34607079 | Copy Number Variation of TLR-7 Gene and its Association with the Development of Systemic Lupus Erythematosus in Female Patients from Yucatan Mexico. |
| Q44027691 | Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice |
| Q44051759 | Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients |
| Q38084889 | Diagnosis and management of infectious complications of childhood rheumatic diseases |
| Q33526071 | Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study |
| Q33750407 | Diversity in presenting manifestations of systemic lupus erythematosus in children |
| Q71988261 | Drug-Induced Lupus |
| Q34118894 | Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose |
| Q80343465 | Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus |
| Q50156154 | Evaluation of abdominal pain in systemic lupus erythematosus |
| Q36527339 | Expression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in Mexico |
| Q57275263 | Expression of recombinant soluble Fc epsilon RI: function and tissue distribution studies |
| Q33379277 | Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. |
| Q35070451 | Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. |
| Q88012035 | Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia |
| Q40558083 | Fever, abdominal pain, and interstitial pneumonia in a 13-year-old female |
| Q34623271 | Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation |
| Q36409505 | Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney |
| Q41584492 | Glucocorticosteroids as immunosuppressive agents |
| Q104073610 | Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods |
| Q81239549 | Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15 |
| Q33853494 | Immunosuppressant and cytotoxic drugs: unapproved uses or indications |
| Q43579581 | Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice |
| Q73748114 | Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice |
| Q44048863 | Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle |
| Q55067043 | Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. |
| Q74033013 | Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE) |
| Q38758838 | Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice |
| Q34989378 | Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus |
| Q28360532 | Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity |
| Q33816779 | NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery |
| Q35546870 | New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation |
| Q35039863 | Newer drugs for the treatment of lupus nephritis |
| Q41377143 | Nocardiosis in systemic lupus erythematosus. |
| Q41525983 | Office evaluation of the patient with musculoskeletal complaints |
| Q36265407 | Papulonodular mucinosis, Guillain-Barré syndrome and nephrotic syndrome in a patient with systemic lupus erythematosus: a case report |
| Q37282608 | Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico |
| Q50571950 | Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF(1) mice. |
| Q36956163 | Prednisolone inhibits PDGF-induced nuclear translocation of NF-kappaB in human pulmonary artery smooth muscle cells |
| Q73737404 | Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus |
| Q41151376 | Psychiatric aspects of rheumatology |
| Q34014604 | Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations |
| Q30887552 | RETRACTED: Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus |
| Q81150257 | Rash, drug hypersensitivity, and autoimmunity in a 20-year-old woman |
| Q41582396 | Recognition and management of systemic lupus erythematosus |
| Q73937818 | Recurrent facial angioedema with elevated antinuclear antibodies |
| Q34161972 | Reduced Expression of TCR Zeta Is Involved in the Abnormal Production of Cytokines by Peripheral T Cells of Patients with Systemic Lupus Erythematosus |
| Q84586160 | Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis |
| Q36929977 | Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. |
| Q78607672 | Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history |
| Q36364479 | Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus |
| Q27006644 | Role of osteopontin in systemic lupus erythematosus |
| Q84078404 | SLE-related longitudinal myelitis with favorable outcome |
| Q36907736 | Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity |
| Q71808640 | Significance of extractable nuclear antigens in childhood autoimmune liver disease |
| Q24669982 | Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes |
| Q79245668 | Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy |
| Q81484697 | Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus |
| Q54911511 | Systemic Lupus Erythematosus in a 12-Year-Old Boy: A Rare Entity in Childhood. |
| Q33362016 | Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report |
| Q50974131 | Systemic lupus erythematosus flares during pregnancy. |
| Q36680344 | Systemic lupus erythematosus presenting as effuso-constrictive pericarditis |
| Q36585823 | TCRzeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients. |
| Q36446357 | The Prevalence of Thyroid Dysfunction in Patients With Systemic Lupus Erythematosus |
| Q28543421 | The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway |
| Q46549173 | The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis |
| Q47416196 | The role of antiphospholipid antibodies (aPls) in infertile women: the long-lasting experience |
| Q37327014 | Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico |
| Q33722879 | Women's health |
| Q80800852 | [The presentation of childhood systemic lupus erythematosus with neurological symptoms: three-case reports] |
Search more.